Contract Manufacturing and Genetic Disease - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Contract Manufacturing

Genetic Disease

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

Pharmaceutical Technology

JULY 29, 2022

In preparation for this, drug manufacturing will begin later this year and will be outsourced to external contract manufacturing organisations (CMOs). In order to find the specific RNA sequences for a genetic disease, the biotech is using an AI- and machine learning-based approach.

RNA

RNA Gene Expression Gene Gene Therapy

Bespoke Gene Therapy Consortium Selects 8 Rare Diseases for Clinical Trial Portfolio

XTalks

MAY 17, 2023

Related: Gene Therapy Clinical Trials for Rare Diseases: 5 Key Takeaways from FDA’s Recent Town Hall “The BGTC offers promise for rare disease patients around the world,” said Julie Gerberding, MD, CEO of the FNIH, in the press release from the agency.

Gene Therapy

Gene Therapy Clinical Trials Clinical Trials Gene

Next Generation Sequencing (NGS) Library Preparation Kits Market: Current Scenario and Future Potential

Roots Analysis

FEBRUARY 21, 2022

The evolution of NGS technologies has made it possible to sequence thousands of genes with a suspected genetic disease predisposition, in a very short period of time and at minimal costs. Nanoparticles Contract Manufacturing. Next Generation Sequencing (NGS) Library Preparation Kits Market – Roots Analysis.

Marketing

Marketing Gene Sequencing DNA Genome

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

Bespoke Gene Therapy Consortium Selects 8 Rare Diseases for Clinical Trial Portfolio

Next Generation Sequencing (NGS) Library Preparation Kits Market: Current Scenario and Future Potential

Webinars

Stay Connected